Primary care physician experiences with integrated pharmacogenomic testing in a community health system

Personalized Medicine
Amy A LemkeHenry M Dunnenberger

Abstract

To explore primary care physicians' views of the utility and delivery of direct access to pharmacogenomics (PGx) testing in a community health system. This descriptive study assessed the perspectives of 15 healthcare providers utilizing qualitative individual interviews. Three main themes emerged: perceived value and utility of PGx testing; challenges to implementation in practice; and provider as well as patient needs. While providers in this study viewed benefits of PGx testing as avoiding side effects, titrating doses more quickly, improving shared decision-making and providing psychological reassurance, challenges will need to be addressed such as privacy concerns, cost, insurance coverage and understanding the complexity of PGx test results.

References

Nov 15, 2007·Qualitative Health Research·Helene Starks, Susan Brown Trinidad
Apr 17, 2010·Public Health Genomics·Wylie BurkeN Press
Jan 29, 2011·Clinical Pharmacology and Therapeutics·M V Relling, T E Klein
Jul 21, 2011·Genetic Testing and Molecular Biomarkers·Susanne B HagaJulianne M O'Daniel
Jan 27, 2012·Clinical Pharmacology and Therapeutics·E J StanekF W Frueh
Feb 9, 2013·Genetic Testing and Molecular Biomarkers·Christina G SelkirkPeter J Hulick
Mar 21, 2013·Genome Medicine·Simone Lucia VernezSandra Soo-Jin Lee
Oct 30, 2013·Pharmacotherapy·Haridarshan N PatelA Simon Pickard
Jul 22, 2014·Pharmacogenomics and Personalized Medicine·Katherine A Johansen Taber, Barry D Dickinson
Aug 12, 2015·The Pharmacogenomics Journal·J F PetersonE W Clayton
Sep 27, 2015·Journal of the American Pharmacists Association : JAPhA·Jivan MoaddebSusanne B Haga
Nov 12, 2015·Pharmacogenomics·Susanne B HagaNancy M Allen LaPointe
Dec 5, 2015·Personalized Medicine·Kim M UnertlJosh F Peterson
Dec 15, 2015·Genetics in Medicine : Official Journal of the American College of Medical Genetics·W David DotsonMuin J Khoury
Mar 2, 2016·Annals of Internal Medicine·Cathelijne H van der WoudenUNKNOWN Impact of Personal Genomics Study Group
Mar 5, 2016·American Journal of Pharmaceutical Education·Solomon M AdamsPhilip E Empey
May 8, 2016·The American Journal of Medicine·Jennifer L St SauverCarolyn R Rohrer Vitek
Jul 13, 2016·Expert Review of Molecular Diagnostics·Susanne B Haga
Aug 24, 2016·Frontiers in Pharmacology·Amber FrickTim Wiltshire
Sep 1, 2016·European Journal of Human Genetics : EJHG·Ritika KapoorYik-Ying Teo
Oct 8, 2016·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Di DongEric Finkelstein
Nov 20, 2016·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Henry M DunnenbergerJanardan Khandekar
Dec 16, 2016·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Barbara LernerMaren T Scheuner
Dec 17, 2016·Drug Discovery Today. Technologies·Leslie J Dickmann, Joseph A Ware
Jan 17, 2017·Clinical Pharmacology and Therapeutics·J A LuzumUNKNOWN Pharmacogenomics Research Network Translational Pharmacogenetics Program
Feb 19, 2017·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Marc B RosenmanMichael T Eadon
Feb 19, 2017·Pharmacology & Therapeutics·Ge Zhang, Daniel W Nebert
Apr 12, 2017·Clinical Pharmacology and Therapeutics·P H O'DonnellM J Ratain
May 4, 2017·Pharmaceutical Research·Kristin W WeitzelLawrence J Lesko

❮ Previous
Next ❯

Citations

May 2, 2018·Personalized Medicine·Adam Tarring
May 30, 2019·British Journal of Clinical Pharmacology·E Abou DiwanN K Zgheib
Dec 5, 2019·Personalized Medicine·Rachele M Hendricks-SturrupJason L Vassy
May 20, 2020·Pharmacogenomics·Youssef M RomanPatricia W Slattum
Aug 10, 2019·Journal of Personalized Medicine·Catriona Hippman, Corey Nislow
Aug 28, 2019·Pharmacogenomics· Natasha PetryApril Schultz
Oct 8, 2019·Pharmacogenomics·Kristin Wiisanen WeitzelCarol R Horowitz
Mar 31, 2019·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Emily J CicaliJulie A Johnson
Oct 5, 2019·The Medical Clinics of North America·Dyson T WakePeter J Hulick
Jan 20, 2021·Pharmacogenomics·Dyson T WakeHenry M Dunnenberger
Apr 15, 2021·Pharmacogenomics·Stephani L StancilSusan Abdel-Rahman
Mar 28, 2021·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Ina LikoYee Ming Lee
May 1, 2021·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Nicholas J KeelingMeagen Rosenthal
Aug 9, 2021·Clinical Pharmacology and Therapeutics·Dyson T WakeHenry M Dunnenberger

❮ Previous
Next ❯

Software Mentioned

ti
Atlas
Plavix
FedEx

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Health Expectations : an International Journal of Public Participation in Health Care and Health Policy
Scott B CantorStephen J Spann
© 2022 Meta ULC. All rights reserved